Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 287-836-1 | CAS number: 85586-34-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 13 July 1981 to 4 September 1981
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Guideline-comparable study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
- Report date:
- 1981
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Principles of method if other than guideline:
- The optimisation test was used, an intracutaneous sensitisation procedure exceeding the sensitivity of the method recommended in the "Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics" (1959), the US Association of Food and Drug Officials (AFDO).
- GLP compliance:
- no
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Guideline-comparable study
Test material
- Reference substance name:
- TK 11'278
- IUPAC Name:
- TK 11'278
- Reference substance name:
- ESBO
- IUPAC Name:
- ESBO
- Reference substance name:
- Epoxidised Soybean Oil
- IUPAC Name:
- Epoxidised Soybean Oil
- Reference substance name:
- Soybean oil, epoxidized
- EC Number:
- 232-391-0
- EC Name:
- Soybean oil, epoxidized
- IUPAC Name:
- 232-391-0
- Reference substance name:
- 8013-07-8
- Cas Number:
- 8013-07-8
- IUPAC Name:
- 8013-07-8
- Reference substance name:
- Soybean oil, epoxidised
- IUPAC Name:
- Soybean oil, epoxidised
- Details on test material:
- - Name of test material (as cited in study report): TK 11'278
- Physical state: Liquid
- Lot/batch No.: prod. Oct. 80
- Expiration date of the lot/batch: January 1982
Constituent 1
Constituent 2
Constituent 3
Constituent 4
Constituent 5
Constituent 6
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Pirbright White
- Sex:
- male/female
- Details on test animals and environmental conditions:
- The test was performed on groups of 10 male and 10 female guinea pigs of the Pirbright White Strain, bred on the premise,s and weighing between 400 to 540 grams.
The animals were housed individually in type 3 Macrolon cages, kept at a constant room temperature of 22 ± 2 °C, at a relative humidity of 55 ± 10 % and in a 12 hour light cycle per day.
The animals were fed standard guinea pig pellets - NAFAG, No. 830, Gossau SG, SWitzerland - ad libitum and had ad libitum access to water.
Bodyweights were recorded immediately before initiation of dosing in the inductin phase and at termination of the study.
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, open
- Vehicle:
- other: propylenglycol 50 % / saline 50 %
- Concentration / amount:
- 0.1 mL of 0.1 % solution of TK 11'278
Challengeopen allclose all
- Route:
- epicutaneous, open
- Vehicle:
- other: propylenglycol 50 % / saline 50 %
- Concentration / amount:
- 0.1 mL of 0.1 % solution of TK 11'278
- No. of animals per dose:
- 10 male and 10 female
- Details on study design:
- The optimisation test was used, an intracutaneous sensitisation procedure exceeding the sensitivity of the method recommended in the "Appraisal of the Safety of Chemical in Foods, Drugs and Cosmetics" (1959), the US Association of Food and Drug Officials (AFDO).
During the induction period the animals received injections every second day (except weekends) to a total of 10 intracutaneous injections of a freshly prepared 0.1 % solution of TK 11'278 in propylenglycol 50 % / saline 50 %. One control group was treated with the vehicle alone ("negative control").
On the first day of week 1, two injections of 0.1 mL were administered into the shaven skin of the right flank and on the following days a single intracutaneous injection was given into the flank.
During the second and third week of the induction period the test material was incroporated in a mixture of saline with complete Bacto Adjuvant. (saline : adjuvant = 1:1)
During week 6 a challenge injection of 0.1 mL of a freshly prepared 0.1 % solution of TK 11'278 in propylenglycol 50 % /saline 50 % was administered into the skin of the left flank.
Twenty-four hours after each injection during the first week of the induction period and 24 hours after the challenge injection the reactions were recorded.
The two largest perpendicular diameters (in mm) and the increase in the skin-fold thickness (in mm) were measured and by multiplication of these values the "reaction volume" was obtained (in µL) for each reading from each animal. The mean volume plus one standard deviation of the induction reactions observed in the individual animal in the first week was taken as representing the skin irritation "threshold" for each animal. Any challenge reaction greater than this threshold value in the induction period was graded as an allergenic reaction and the animal termed "positive". The number of "positive" animals in the test group was compared with the number of animals in the control group (treated with the vehicle alone) that showed a non-specific reaction of at least the same magnitude ("negative control").
During week 8 a subirritant dose (30 % TK 11'278 in vaseline) of the test compound was applied epicutaneously under occlusive dressings which were left in place for 24 hours. The skin irritation was recorded according to Draize (described in the "Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics" 1959 of the US Association of Food and Drug Officials (AFD0) 24 hours after removal of the dressings. For irritation score see table below:
Score for Skin Irritation
Erythema and eschar formation
No erythema........................................................ 0
Very slight erythema (barely perceptible) ...... 1
Well defined erythema ....................................... 2
Moderate to severe erythema .......................... 3
Severe erythema (beed redness) to slight
eschar formation (injuries in depth) ...............4
Total Possible Erythema Score .........................4 - Challenge controls:
- No data
- Positive control substance(s):
- no
Results and discussion
- Positive control results:
- No data
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. No with. + reactions: 2.0. Total no. in groups: 20.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. No with. + reactions: 2.0. Total no. in groups: 20.0.
Any other information on results incl. tables
No further data to report.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- No evidence of skin sensitisation was seen under the conditions of this study
- Executive summary:
The skin sensitisation potential of the read-across substance ESBO (epoxidised soybean oil) was assessed in a guinea pig study. No evidence of skin sensitisation was seen under the conditions of this study; a comparable level of reactions was seen following challenge exposure in test and control animals.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.